682
Participants
Start Date
September 23, 2013
Primary Completion Date
January 11, 2016
Study Completion Date
January 11, 2016
Boostrix
Single intramuscular injection
Safety data collection
Safety monitoring: recording of adverse events using diary cards and recording of serious adverse events using the latest version of Korea's Post-Marketing Surveillance Serious Adverse Event Reporting Form
GSK Investigational Site, Suwon
Lead Sponsor
GlaxoSmithKline
INDUSTRY